0001179110-19-003597.txt : 20190308 0001179110-19-003597.hdr.sgml : 20190308 20190308152734 ACCESSION NUMBER: 0001179110-19-003597 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190306 FILED AS OF DATE: 20190308 DATE AS OF CHANGE: 20190308 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DArecca James CENTRAL INDEX KEY: 0001583903 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36867 FILM NUMBER: 19668910 MAIL ADDRESS: STREET 1: 400 INTERPACE PARKWAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Allergan plc CENTRAL INDEX KEY: 0001578845 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CLONSHAUGH BUSINESS AND TECHNOLOGY PARK CITY: COOLOCK, DUBLIN STATE: L2 ZIP: D17 E400 BUSINESS PHONE: (216) 523-5000 MAIL ADDRESS: STREET 1: CLONSHAUGH BUSINESS AND TECHNOLOGY PARK CITY: COOLOCK, DUBLIN STATE: L2 ZIP: D17 E400 FORMER COMPANY: FORMER CONFORMED NAME: Actavis plc DATE OF NAME CHANGE: 20130930 FORMER COMPANY: FORMER CONFORMED NAME: Actavis Ltd DATE OF NAME CHANGE: 20130607 4 1 edgar.xml FORM 4 - X0306 4 2019-03-06 0 0001578845 Allergan plc AGN 0001583903 DArecca James CLONSHAUGH BUSINESS AND TECHNOLOGY PARK, COOLOCK, CO. DUBLIN L2 D17 E400 IRELAND 0 1 0 0 SVP Chief Accounting Officer Ordinary Shares, par value $0.0001 2019-03-06 4 A 0 2036 137.51 A 7505 D The reported securities are restricted share units, each of which represents a right to receive one ordinary share of Allergan plc. The restricted share units will vest twenty-five percent (25%) on March 6, 2020, twenty-five percent (25%) on March 6, 2021, twenty-five percent (25%) on March 6, 2022 and twenty-five percent (25%) on March 6, 2023. Includes restricted stock units issued pursuant to the 2013 Incentive Award Plan of Allergan plc. /s/ A. Robert D. Bailey, Attorney-in-Fact for the Reporting Person 2019-03-08